A review on the role of carnitine in the management of tamoxifen side effects in treated women with breast cancer

被引：12
作者：
El-Ashmawy, Nahla E. [1 ]
Khalil, Rania M. [2 ]
机构：
[1] Tanta Univ, Dept Biochem, Fac Pharm, Tanta, Egypt
[2] Delta Univ, Dept Biochem, Fac Pharm, Gamasah, Egypt
来源：
TUMOR BIOLOGY | 2014年 / 35卷 / 04期
关键词：
Breast cancer; Cancer prognosis; L-carnitine; Resistance; Side effects; Tamoxifen; ACETYL-L-CARNITINE; RANDOMIZED DOUBLE-BLIND; PROPIONYL-L-CARNITINE; FATTY-ACID SYNTHASE; GROWTH-FACTOR-I; POSTMENOPAUSAL WOMEN; OXIDATIVE STRESS; DEPRESSED MOOD; HUMAN CORNEAL; FATIGUE;
D O I：
10.1007/s13277-013-1477-5
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
l-carnitine is an antioxidant and is found to be a protective agent against many diseases including cancer. This review illustrates the possible role of l-carnitine as an add-on therapy to breast cancer patients maintained on tamoxifen. The objectives of carnitine treatment are diverse: improving tamoxifen-related side effects, offering better cancer prognosis by reducing the risk of developing cancer recurrence or metastasis, and modulating the growth factors which may be, in part, a prospective illustration to overcome tamoxifen resistance. So, it could be recommended to supplement l-carnitine to breast cancer patients starting tamoxifen treatment.
引用
收藏
页码：2845 / 2855
页数：11
相关论文
共 50 条
  • [21] Therapeutic approach to ovarian cysts in tamoxifen-treated women with breast cancer
    Shushan, A
    Peretz, T
    MorYosef, S
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 1996, 52 (03) : 249 - 253
  • [22] Ocular side-effects in breast cancer patients treated with tamoxifen and toremifene: a randomized follow-up study
    Parkkari, M
    Paakkala, AM
    Salminen, L
    Holli, K
    ACTA OPHTHALMOLOGICA SCANDINAVICA, 2003, 81 (05): : 495 - 499
  • [23] Age-related differences in persistence in women with breast cancer treated with tamoxifen or aromatase inhibitors in Germany
    Jacob, Louis
    Hadji, Peyman
    Kostev, Karel
    JOURNAL OF GERIATRIC ONCOLOGY, 2016, 7 (03) : 169 - 175
  • [24] Endometrial Surveillance in Tamoxifen and Letrozole Treated Breast Cancer Patients
    AlZaabi, Adhari
    AlAmri, Hafsa
    ALAjmi, Ghadeer
    Allawati, Manhal
    Muhanna, Fatema
    Alabri, Ruqaia
    AlBusaidi, Fatema
    AlGhafri, Shaima
    Al-Mirza, Abdulrahman A.
    Al Baimani, Khalid
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (11)
  • [25] Side-effects in women treated with adjuvant endocrine therapy for breast cancer
    Rademaker, L. M.
    Gal, R.
    May, A. M.
    Batenburg, M. C. T.
    van der Leij, F.
    Bijlsma, R. M.
    Verkooijen, H. M.
    Doeksen, A.
    Ernst, M. F.
    Evers, D. J.
    van der Pol, C. C.
    Monninkhof, E. M.
    BREAST, 2025, 80
  • [26] Elastosonographic evaluation of endometrium in women using tamoxifen for breast cancer
    Gultekin, I. B.
    Imamoglu, G. I.
    Gultekin, S.
    Yilmaz, E. A.
    Yilmaz, Z.
    Alkan, A.
    Kucukozkan, T.
    NIGERIAN JOURNAL OF CLINICAL PRACTICE, 2019, 22 (01) : 92 - 100
  • [27] Effects of treatment with chemotherapy and/or tamoxifen on the biomarkers of cardiac injury and oxidative stress in women with breast cancer
    Silva, Fabricio Braganca
    Romero, Walckiria Garcia
    de Abreu Carvalho, Ana Ligia Rodrigues
    Alves Souza, Gleyce Ariadne
    Goncalves Claudio, Erick Roberto
    Abreu, Glaucia Rodrigues
    MEDICINE, 2017, 96 (47)
  • [28] Evaluation of endometrium by transvaginal ultrasonography and Doppler in tamoxifen-treated women with breast cancer
    Bezircioglu, I.
    Baloglu, A.
    Tarhan, M. O.
    Oziz, E.
    Yigit, S.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2012, 33 (03) : 295 - 299
  • [29] Adjuvant radiotherapy of women with breast cancer - Information, support and side-effects
    Sjovall, K.
    Strombeck, G.
    Lofgren, A.
    Bendahl, P-O
    Gunnars, B.
    EUROPEAN JOURNAL OF ONCOLOGY NURSING, 2010, 14 (02) : 147 - 153
  • [30] Tamoxifen for women at high risk of breast cancer
    Nazarali, Safia A.
    Narod, Steven A.
    BREAST CANCER-TARGETS AND THERAPY, 2014, 6 : 29 - 36
12345